6-32044149-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001365276.2(TNXB):​c.11264-20G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.019 in 1,471,384 control chromosomes in the GnomAD database, including 548 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.016 ( 56 hom., cov: 19)
Exomes 𝑓: 0.019 ( 492 hom. )

Consequence

TNXB
NM_001365276.2 intron

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.64

Publications

0 publications found
Variant links:
Genes affected
TNXB (HGNC:11976): (tenascin XB) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TNXB Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome due to tenascin-X deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Illumina, PanelApp Australia, Orphanet
  • familial vesicoureteral reflux
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • vesicoureteral reflux 8
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 6-32044149-C-T is Benign according to our data. Variant chr6-32044149-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 261104.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0162 (2150/132592) while in subpopulation NFE AF = 0.0235 (1443/61452). AF 95% confidence interval is 0.0225. There are 56 homozygotes in GnomAd4. There are 1059 alleles in the male GnomAd4 subpopulation. Median coverage is 19. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 56 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNXBNM_001365276.2 linkc.11264-20G>A intron_variant Intron 33 of 43 ENST00000644971.2 NP_001352205.1
TNXBNM_001428335.1 linkc.12005-20G>A intron_variant Intron 34 of 44 NP_001415264.1
TNXBNM_019105.8 linkc.11258-20G>A intron_variant Intron 33 of 43 NP_061978.6
TNXBNM_032470.4 linkc.551-20G>A intron_variant Intron 2 of 12 NP_115859.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNXBENST00000644971.2 linkc.11264-20G>A intron_variant Intron 33 of 43 NM_001365276.2 ENSP00000496448.1

Frequencies

GnomAD3 genomes
AF:
0.0163
AC:
2155
AN:
132510
Hom.:
57
Cov.:
19
show subpopulations
Gnomad AFR
AF:
0.00318
Gnomad AMI
AF:
0.0151
Gnomad AMR
AF:
0.00537
Gnomad ASJ
AF:
0.0194
Gnomad EAS
AF:
0.0195
Gnomad SAS
AF:
0.0132
Gnomad FIN
AF:
0.0315
Gnomad MID
AF:
0.0304
Gnomad NFE
AF:
0.0235
Gnomad OTH
AF:
0.0139
GnomAD2 exomes
AF:
0.0185
AC:
3726
AN:
201420
AF XY:
0.0187
show subpopulations
Gnomad AFR exome
AF:
0.00287
Gnomad AMR exome
AF:
0.00922
Gnomad ASJ exome
AF:
0.0197
Gnomad EAS exome
AF:
0.0216
Gnomad FIN exome
AF:
0.0295
Gnomad NFE exome
AF:
0.0216
Gnomad OTH exome
AF:
0.0214
GnomAD4 exome
AF:
0.0192
AC:
25760
AN:
1338792
Hom.:
492
Cov.:
31
AF XY:
0.0192
AC XY:
12779
AN XY:
665472
show subpopulations
African (AFR)
AF:
0.00261
AC:
80
AN:
30612
American (AMR)
AF:
0.00919
AC:
363
AN:
39516
Ashkenazi Jewish (ASJ)
AF:
0.0197
AC:
492
AN:
24928
East Asian (EAS)
AF:
0.0123
AC:
461
AN:
37624
South Asian (SAS)
AF:
0.0147
AC:
1142
AN:
77604
European-Finnish (FIN)
AF:
0.0288
AC:
1397
AN:
48426
Middle Eastern (MID)
AF:
0.0209
AC:
87
AN:
4162
European-Non Finnish (NFE)
AF:
0.0204
AC:
20787
AN:
1020046
Other (OTH)
AF:
0.0170
AC:
951
AN:
55874
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.528
Heterozygous variant carriers
0
764
1527
2291
3054
3818
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
708
1416
2124
2832
3540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0162
AC:
2150
AN:
132592
Hom.:
56
Cov.:
19
AF XY:
0.0165
AC XY:
1059
AN XY:
64068
show subpopulations
African (AFR)
AF:
0.00317
AC:
109
AN:
34388
American (AMR)
AF:
0.00529
AC:
70
AN:
13230
Ashkenazi Jewish (ASJ)
AF:
0.0194
AC:
62
AN:
3204
East Asian (EAS)
AF:
0.0195
AC:
89
AN:
4554
South Asian (SAS)
AF:
0.0130
AC:
50
AN:
3856
European-Finnish (FIN)
AF:
0.0315
AC:
284
AN:
9026
Middle Eastern (MID)
AF:
0.0219
AC:
6
AN:
274
European-Non Finnish (NFE)
AF:
0.0235
AC:
1443
AN:
61452
Other (OTH)
AF:
0.0138
AC:
25
AN:
1814
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.556
Heterozygous variant carriers
0
70
140
209
279
349
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0214
Hom.:
22
Bravo
AF:
0.0141

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.020
DANN
Benign
0.56
PhyloP100
-1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77466839; hg19: chr6-32011926; API